ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.520,38
0,03%
S&P 500
5.237,88
0,05%
Dow Jones
38.163,94
0,14%
Euro vs US Dollar
1,08723
0,38%
Bitcoin
67.899,37
-0,68%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Centessa Pharmaceuticals PLC (CNTA)

  7. Centessa Pharmaceuticals PLC (CNTA) News

CNTA Centessa Pharmaceuticals PLC

8,29
0,17 (2,09%)
Zuletzt aktualisiert: 15:50:20
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Centessa Pharmaceuticals PLC CNTA NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,17 2,09% 8,29 15:50:20
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
8,25 8,25 8,48 8,12
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
21.5.202414:45GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
13.5.202422:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.5.202422:23EDGAR2Form 8-K - Current report
13.5.202422:10GLOBECentessa Pharmaceuticals Reports Financial Results and..
09.5.202414:01EDGAR2Form ARS - Annual Report to Security Holders
09.5.202414:00EDGAR2Form DEF 14A - Other definitive proxy statements
24.4.202403:36GLOBECentessa Pharmaceuticals Announces Pricing of $100 Million..
23.4.202422:17GLOBECentessa Pharmaceuticals Announces $100 Million Proposed..
22.4.202413:00GLOBECentessa Pharmaceuticals Announces Open IND for ORX750;..
28.3.202421:28GLOBECentessa Pharmaceuticals Reports Business Highlights and..
22.2.202414:00GLOBECentessa Pharmaceuticals to Participate in TD Cowen’s 44th..
09.2.202413:12EDGAR2Form 8-K - Current report
09.2.202413:00GLOBECentessa Pharmaceuticals to Present Additional 52-Weeks of..
02.2.202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202422:07EDGAR2Form 144 - Report of proposed sale of securities
22.1.202414:00GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
09.1.202413:56EDGAR2Form 8-K - Current report
03.1.202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202401:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202401:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202314:00GLOBECentessa Pharmaceuticals to Present at the 42ⁿᵈ Annual J.P...
11.12.202313:05EDGAR2Form 8-K - Current report
10.12.202318:05GLOBECentessa Pharmaceuticals Announces New Data from an..
27.11.202322:15GLOBEAnaptys Expands Immune Cell Modulator Pipeline with..
13.11.202322:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202322:17EDGAR2Form 8-K - Current report
13.11.202322:05GLOBECentessa Pharmaceuticals Reports Financial Results and..
02.11.202314:09GLOBECentessa Pharmaceuticals to Present Additional 52-Weeks of..
31.10.202313:00GLOBECentessa Pharmaceuticals Announces Dosing of First Subject..
30.10.202313:00GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
25.10.202315:49EDGAR2Form 8-K - Current report
25.10.202314:00GLOBECentessa Pharmaceuticals Announces Preclinical Data..
03.10.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202322:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202314:00GLOBECentessa Pharmaceuticals Announces Additions to Senior..
22.9.202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.9.202322:02EDGAR2Form 144 - Report of proposed sale of securities
01.9.202322:31EDGAR2Form 144 - Report of proposed sale of securities
31.8.202314:00GLOBECentessa Pharmaceuticals to Participate in the Morgan..
23.8.202323:08GLOBECentessa Pharmaceuticals to Present Preclinical Data for..
14.8.202313:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Kürzlich von Ihnen besucht

NASDAQ
CNTA
Centessa Pharmaceuticals
EU
BELTL
BEL 20 Total Return Leve...
NASDAQ
CADTU
DT ASIA INVESTMENTS LTD
GATE
BMONUSDT
Binamon
TG
EY3
Century Aluminum
TG
DUT
Moodys
TG
3CM
RLX Technology
TG
1SZ
Santacruz Silver Mining
POLO
COMPETH
Compound
BIT
UC7Z06
Unicredit Bank
COIN
OPEPEUST
Ordinal Pepe
USOTC
JPPTY
Japan Post Bank (PK)
LSE
IBGE
Ishr E Gov 0-1
USOTC
GNMLF
Genoma Lab International... (PK)
NASDAQ
MXDYE
Maximum Dynmanics
LSE
0N8L
Decotex Ad
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten